Primary record
Cytidine, 2',3'-dideoxy-; 2',3'-Dideoxycytidine; D 2C; Dideoxycytidine; Hivid; NSC 606170; Ro 24-2027/000; Zalcitabine; ddC
- 库存
- 3,607 克
- 纯度
- 98.7 %
- CAS
- 7481-89-2
化合物标识与属性
- CAS
- 7481-89-2
- PubChem CID
- 24066
- SMILES
- C1C[C@@H](O[C@@H]1CO)N2C=CC(=NC2=O)N
- Canonical SMILES
- Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1
名称与同义词
- zalcitabine
- Dideoxycytidine
- 2',3'-DIDEOXYCYTIDINE
- ddCyd
- HIVID
- 7481-89-2
- Zalcitibine
- zalcitabina
- ddC (Antiviral)
- Cytidine, 2',3'-dideoxy-
- zalcitabinum
- Zalcitabine?
- 2,3-dideoxycytidine
- HIVID Roche
- Hivid(TM)
- Zalcitabine(DDC)
- Hivid (TN)
- Beta-D-DDC
- DdC & IFN-alpha
- C9H13N3O3
- ddC & sCD4
- 2',3' Dideoxycytidine
- ddC & GM-CSF
- PC-SOD & ddC
- ddC & IFN.alpha.
- .beta.-D-DDC
- dideoxycytidine (DDC)
- Interferon AD + ddC
- 2', 3'-dideoxycytidine
- 6L3XT8CB3I
- Zalcitabine (Standard)
- CCRIS 692
- CHEMBL853
- DdC & Interferon alpha
- DDC (DDC)
- UNII-6L3XT8CB3I
- DTXSID0023747
- ZALCITABINE [MI]
- Prestwick0_001037
- Prestwick1_001037
- Prestwick2_001037
- Prestwick3_001037
- RefChem:389367
- Zalcitabine [USAN:INN:BAN]
- ddC & Interferon.alpha.
- ZALCITABINE [INN]
- ZALCITABINE [JAN]
- NSC 606170
- WREGKURFCTUGRC-POYBYMJQSA-N
- MFCD00012188
- ZALCITABINE [HSDB]
- ZALCITABINE [IARC]
- ZALCITABINE [USAN]
- bmse000712
- D0DC7N
- D0M1YO
- D0Z9QR
- UPCMLD-DP115
- Zalcitabine (JAN/USP/INN)
- HSDB 7156
- ZALCITABINE [VANDF]
- AC1L2N6R
- SCHEMBL3598
- DTXCID703747
- TimTec1_004969
- DS-4152 & ddC
- ZALCITABINE [MART.]
- 2',3'-Dideoxy-D-cytidine
- Lopac0_000360
- BSPBio_001253
- Ro 24-2027/000
- Ro-24-2027/000
- ZALCITABINE [USP-RS]
- ZALCITABINE [WHO-DD]
- CHEBI:10101
- ddC
- MLS000069636
- MLS000759540
- MLS001055363
- MLS001424210
- MLS006011951
- NSC-606170
- Zalcitabine (dideoxycytidine,ddc)
- SPBio_003104
- NSC606170
- Zalcitabine [USAN:BAN:INN]
- 2 ,3 -Dideoxycytidine
- BPBio1_001378
- GTPL4828
- orb1310928
- 2',3'-ddC
- ddC & NP (from PHCA or HSA)
- ddC|||2',3'-Dideoxycytidine
- 4-Amino-1-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
- SCHEMBL10378805
- SRI-7707
- UPCMLD-DP115:001
- Zalcitabine - Bio-X trade mark
- Zalcitabine [USAN:USP:INN:BAN]
- KS-00000MRJ
- ZINC39906
- AOB5609
- BRN 0654956
- J05AF03
- ZALCITABINE [ORANGE BOOK]
- GLXC-06578
- HMS1548B19
- HMS1571O15
- HMS2051H18
- HMS2090C12
- HMS2098O15
- HMS2236N08
- HMS3261G21
- HMS3715O15
- Pharmakon1600-01502360
- ZALCITABINE [USP IMPURITY]
- .beta.-D-2',3'-Dideoxycytidine
- Zalcitabine, 2'3'-Dideoxycytidine
- BCP13878
- CID24066
- KS-1130
- Hivid;Dideoxycytidine;NSC 606170
- Ro-242027000
- Tox21_113491
- Tox21_201655
- Tox21_303169
- Tox21_500360
- AC-824
- ANW-36530
- BDBM50145605
- C9-H13-N3-O3
- CID:24066
- EBC-07537
- HY-17392R
- NCGC00090705-08
- NSC759655
- Ro-24-2027000
- s1719
- SBB066036
- AKOS015854844
- AKOS015894505
- Tox21_113491_1
- 1-(2,3-Dideoxy-beta-D-ribofuranosyl)cytosine
- BETA-D-2',3'-DIDEOXYCYTIDINE
- CCG-101050
- CS-1110
- DB00943
- LP00360
- LS-1645
- NC00300
- ND06559
- NSC-759655
- RTC-064018
- SDCCGSBI-0050348.P002
- SRI-7707-13
- SRI-7707-14
- SRI-7707_15
- SRI-7707_17
- NCGC00090705-01
- NCGC00090705-02
- NCGC00090705-03
- NCGC00090705-05
- NCGC00090705-06
- NCGC00090705-07
- NCGC00090705-09
- NCGC00090705-10
- NCGC00090705-11
- NCGC00090705-13
- NCGC00090705-15
- NCGC00090705-24
- NCGC00090705-25
- NCGC00179242-01
- NCGC00257202-01
- NCGC00259204-01
- NCGC00261045-01
- AJ-08916
- AN-15472
- BC203863
- BD164564
- BP-58631
- CPD000058253
- HY-17392
- K278
- SAM001246779
- SC-09165
- SID:53788261
- SMR000058253
- ST069364
- SY106119
- ZB001188
- 2',3'-Dideoxycytidine & Interferon-alpha
- 2',3'-Dideoxycytidine;ddC;Dideoxycytidine
- CAS-7481-89-2
- D 5782
- ddC;Dideoxycytidine;2',3'-Dideoxycytidine
- 2',3'-Dideoxycytidine & Interferon.alpha.
- 2',3'-Dideoxycytidine, >=98% (HPLC)
- AB0014137
- AB2000246
- DB-019728
- J277.119E
- TC-064018
- B2223
- D3581
- EU-0100360
- NS00005543
- ST24043185
- SW197364-4
- 5-25-14-00313 (Beilstein Handbook Reference)
- Cytidine, 2',3'-dideoxy & Interferon alpha
- Ro-24-2027-000
- C07207
- C76390
- D00412
- EN300-120633
- M-2084
- 2',3'-DIDEOXYCYTIDINE-5'-MONOPHOSPHATE
- 4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
- 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one
- 42060-EP2295503A1
- 42060-EP2298761A1
- 42060-EP2305695A2
- 42060-EP2305696A2
- 42060-EP2305697A2
- 42060-EP2305698A2
- 42060-EP2311808A1
- 42060-EP2311829A1
- 78798-EP2298783A1
- 78798-EP2305695A2
- 78798-EP2305696A2
- 78798-EP2305697A2
- 78798-EP2305698A2
- Cytidine, 2',3'-dideoxy- & Interferon.alpha.
- 481D892
- A838234
- D016047
- F222318
- Hivid, Dideoxycytidine, NSC 606170, Zalcitabine
- SR-01000075822
- SR-01000736919
- ZALCITABINE (DIDEOXYCYTIDINE,DDC) [VANDF]
- 2',3'-Dideoxycytidine & sCD4(soluble recombinant protein)
- 3'-Azido-3'-deoxythymidine/2',3'-Dideoxycytidine
- Q2344582
- SR-01000075822-1
- SR-01000736919-5
- 4-AMINO-1-[(2R,5S)-5-(HYDROXYMETHYL)OXOLAN-2-YL]-1,2-DIHYDROPYRIMIDIN-2-ONE
- BRD-K85925969-001-16-6
- BRD-K85925969-001-17-4
- Cytidine, 2',3'-dideoxy- & Colony-stimulating factor
- Cytidine, 2',3'-dideoxy-& Colony-stimulating factor
- 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one
- Ro-242027000/Ro-24-2027-000
- Z1550648753
- 4-amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
- Lecithinized superoxide dismutase & .beta.-D-2',3'-Dideoxycytidine
- Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxycytidine
- 1-(dichloromethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole
- 2',3'-Dideoxycytidine & Nanoparticles (from human serum albumin or polyhexylcyanoacrylate)
- 4-amino-1-((2R,5S)-5-(hydroxymethyl)oxolan-2-yl)pyrimidin-2-one
- 4-Amino-1-(2,3-dideoxy-beta-D-ribofuranosyl)pyrimidine-2(1H)-one
- Zalcitabine, United States Pharmacopeia (USP) Reference Standard
- 2 inverted exclamation mark ,3 inverted exclamation mark -Dideoxycytidine
- 2 inverted exclamation marka,3 inverted exclamation marka-Dideoxycytidine
- 3-[(5S,2R)-5-(hydroxymethyl)oxolan-2-yl]-6-amino-3-hydropyrimidin-2-one
- 4-Amino-1-(5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one
- 4-Amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2(1H)-one
- .beta.-D-2',3'-Dideoxycytidine & Granulocyte-macrophage colony-stimulating factor
- 4-amino-1-((2R,5S)-5-(hydroxymethyl)oxolan-2-yl)-1,2-dihydropyrimidin-2-one
- Beta-D-2',3'-Dideoxycytidine & Granulocyte-macrophage colony-stimulating factor
- 107-95-9
- 620-762-3
- 748110-64-7
- Cytidine, 2',3'-dideoxy-; 2',3'-Dideoxycytidine; D 2C; Dideoxycytidine; Hivid; NSC 606170; Ro 24-2027/000; Zalcitabine; ddC
- D2C
- DOC